There is evidence that amyloid deposition within the brain is of major importance in the pathogenesis of Alzheimer's disease (AD), but the mechanism of this deposition is not known, and several theories are currently under great debate. The present study of intraneuronal changes in the human brain with age and disease suggests a new explanation for amyloid plaque formation in the pathogenesis of AD.This work indicates that intraneuronal inclusions originally observed by Rees (1975), may contain amyloid peptide (Abeta), the beta-pleated form of which is the major component of the amyloid plaques in AD. We have therefore called them amylosomes. Using the techniques of histology, immunohistochemistry, computerized morphology, as well as protei...
Growing evidence gathered from transgenic animal models of Alzheimer’s disease (AD) indicates that t...
The 4.2-kilodalton (kDa) polypeptide associated with the cerebral amyloid deposits of Alzheimer\u27s...
Background: beta-Amyloid (A beta) plaques are a pathological hallmark of Alzheimer's disease (AD) an...
Amyloid deposition in cortical plaques and around cerebral vessels is a hallmark of Alzheimer's dise...
A conclusive diagnosis of Alzheimer's disease (AD) can be made only by correlating clinical findings...
Alzheimer’s disease begins about two decades before the onset of symptoms or neuron death, and is be...
This work provides new insight into the age-related basis of Alzheimer's disease (AD), the compositi...
With respect to the pathogenesis of Alzheimer's disease (AD), it has been hypothesized that amorphou...
Cumulative evidence in brains and cultured neurons of Alzheimer's disease (AD) transgenic mouse mode...
Biochemical studies show that phosphorylated τ, like that found in paired helical filaments (PHFs), ...
Alzheimer’s Disease (AD) is a devastating neurodegenerative disorder that is histopathologically cha...
Inside and outside the brain, accumulation of amyloid fibrils plays key roles in the pathogenesis of...
Pathologic aggregation of beta-amyloid (A beta) peptide and the axonal microtubule-associated protei...
Pathologic aggregation of b-amyloid (Ab) peptide and the axonal microtubule-associated protein tau p...
The amount of microtubule protein present in the total soluble protein from brains of Alzheimer's di...
Growing evidence gathered from transgenic animal models of Alzheimer’s disease (AD) indicates that t...
The 4.2-kilodalton (kDa) polypeptide associated with the cerebral amyloid deposits of Alzheimer\u27s...
Background: beta-Amyloid (A beta) plaques are a pathological hallmark of Alzheimer's disease (AD) an...
Amyloid deposition in cortical plaques and around cerebral vessels is a hallmark of Alzheimer's dise...
A conclusive diagnosis of Alzheimer's disease (AD) can be made only by correlating clinical findings...
Alzheimer’s disease begins about two decades before the onset of symptoms or neuron death, and is be...
This work provides new insight into the age-related basis of Alzheimer's disease (AD), the compositi...
With respect to the pathogenesis of Alzheimer's disease (AD), it has been hypothesized that amorphou...
Cumulative evidence in brains and cultured neurons of Alzheimer's disease (AD) transgenic mouse mode...
Biochemical studies show that phosphorylated τ, like that found in paired helical filaments (PHFs), ...
Alzheimer’s Disease (AD) is a devastating neurodegenerative disorder that is histopathologically cha...
Inside and outside the brain, accumulation of amyloid fibrils plays key roles in the pathogenesis of...
Pathologic aggregation of beta-amyloid (A beta) peptide and the axonal microtubule-associated protei...
Pathologic aggregation of b-amyloid (Ab) peptide and the axonal microtubule-associated protein tau p...
The amount of microtubule protein present in the total soluble protein from brains of Alzheimer's di...
Growing evidence gathered from transgenic animal models of Alzheimer’s disease (AD) indicates that t...
The 4.2-kilodalton (kDa) polypeptide associated with the cerebral amyloid deposits of Alzheimer\u27s...
Background: beta-Amyloid (A beta) plaques are a pathological hallmark of Alzheimer's disease (AD) an...